Select Agent Program

Dr. Patterson's research program includes work on a vaccine for Lassa fever virus. An arenavirus that causes hemorrhagic fever, Lassa fever affects between 300,000 and 500,000 people in West Africa. In collaboration with the Institute of Human Virology at the University of Maryland, Dr. Patterson and her team have begun tests on a live attenuated vaccine. Her laboratory recently developed a high-throughput antiviral screen specifically for viruses that can only be studied in BSL-4 laboratories.

Through other research efforts, Dr. Patterson and her team continue to work with the Department of Defense on projects involved with government’s attempt to block the proliferation of biological weapons, including anthrax, tularensis, and other select agents.